226916-29-6 Usage
Uses
Used in Organic Chemistry:
(1'R,3a'R,4a'R,8a'R,9'R,9a'S)-1',8a'-dimethyl-3'-oxodecahydro-1'H-spiro[[1,3]dioxolane-2,6'-naphtho[2,3-c]furan]-9'-carbaldehyde serves as a valuable intermediate in the synthesis of more complex organic molecules due to its reactive functional groups and unique spiro structure.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, (1'R,3a'R,4a'R,8a'R,9'R,9a'S)-1',8a'-dimethyl-3'-oxodecahydro-1'H-spiro[[1,3]dioxolane-2,6'-naphtho[2,3-c]furan]-9'-carbaldehyde may be utilized as a precursor for the development of novel drugs, given its potential to form a variety of chemical derivatives and its capacity to interact with biological targets due to its structural complexity.
Used in Materials Science:
(1'R,3a'R,4a'R,8a'R,9'R,9a'S)-1',8a'-dimethyl-3'-oxodecahydro-1'H-spiro[[1,3]dioxolane-2,6'-naphtho[2,3-c]furan]-9'-carbaldehyde could be employed in the design of new materials with specific properties, such as in the creation of advanced polymers or as part of molecular devices, owing to its versatile chemical structure.
Check Digit Verification of cas no
The CAS Registry Mumber 226916-29-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,6,9,1 and 6 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 226916-29:
(8*2)+(7*2)+(6*6)+(5*9)+(4*1)+(3*6)+(2*2)+(1*9)=146
146 % 10 = 6
So 226916-29-6 is a valid CAS Registry Number.
226916-29-6Relevant academic research and scientific papers
Metabolism-based identification of a potent thrombin receptor antagonist
Clasby, Martin C.,Chackalamannil, Samuel,Czarniecki, Michael,Doller, Dario,Eagen, Keith,Greenlee, William,Kao, Grace,Lin, Yan,Tsai, Hsingan,Xia, Yan,Ahn, Ho-Sam,Agans-Fantuzzi, Jacqueline,Boykow, George,Chintala, Madhu,Foster, Carolyn,Smith-Torhan, April,Alton, Kevin,Bryant, Matthew,Hsieh, Yunsheng,Lau, Janice,Palamanda, Jairam
, p. 129 - 138 (2008/02/03)
The metabolism of our prototypical thrombin receptor antagonist 1, K i = 2.7 nM, was studied and three major metabolites (2, 4, and 5) were found. The structures of the metabolites were verified independently by synthesis. Compound 4 was shown